Nilotinib Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Ovarian, Colorectal, or Appendiceal Cancer
Conditions:   Peritoneal Carcinomatosis;   Peritoneal Neoplasms;   Ovarian Cancer;   Ovarian Neoplasms;   Colorectal Cancer;   Colorectal Neoplasms;   Appendiceal Cancer;   Appendiceal Neoplasms Interventions:   Drug: Paclitaxel;   Drug: Nilotinib Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2022 Category: Research Source Type: clinical trials